Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q9)Sep 30, 2025 | (Q6)Jun 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||
| Current assets | ||||||||||
| Money funds | 25.75%455.38M | 44.48%647.63M | -44.80%432.85M | -67.42%300M | -71.73%362.14M | -52.85%448.26M | -5.44%784.08M | 14.26%920.82M | 265.34%1.28B | 223.71%950.77M |
| Transactional financial assets | -54.10%160.93M | -52.35%190.93M | 15.93%221.03M | 327.24%301.98M | 248.49%350.65M | -24.71%400.71M | -71.57%190.65M | -90.40%70.68M | --100.62M | --532.2M |
| Notes receivable and accounts receivable | 25.81%1.88B | 30.95%1.71B | 45.73%1.73B | 22.11%1.63B | 27.44%1.49B | 12.59%1.3B | 27.94%1.19B | 40.53%1.33B | 5.99%1.17B | -17.60%1.16B |
| -Notes receivable | 338.14%269.86M | 1,762.51%203.77M | 645.65%306.73M | 799.20%355.69M | 55.78%61.59M | 47.74%10.94M | 19,874.05%41.14M | 385.06%39.56M | 491.05%39.54M | -14.64%7.41M |
| -Accounts receivable | 12.37%1.61B | 16.28%1.5B | 24.22%1.42B | -1.65%1.27B | 26.45%1.43B | 12.37%1.29B | 23.54%1.15B | 37.54%1.29B | 3.04%1.13B | -17.61%1.15B |
| Other receivables (including interest and dividends) | 31.52%285.87M | 45.07%282.7M | 91.85%350.75M | 60.41%324.4M | 77.46%217.36M | 248.23%194.87M | 311.12%182.83M | 1,779.43%202.23M | -44.97%122.48M | -74.13%55.96M |
| -Other receivable | ---- | 45.07%282.7M | ---- | ---- | ---- | 248.23%194.87M | ---- | 1,779.43%202.23M | ---- | -74.13%55.96M |
| Advance payment | -11.53%272.42M | -5.38%229.17M | -47.51%222.38M | 9.96%256.93M | -36.93%307.91M | 30.83%242.2M | 24.08%423.65M | -23.64%233.66M | 18.42%488.24M | -16.80%185.12M |
| Inventories | 9.22%2.68B | 16.78%2.63B | 23.70%2.65B | 18.42%2.41B | 15.74%2.45B | 5.46%2.25B | 6.38%2.14B | 3.18%2.04B | 33.44%2.12B | 20.21%2.13B |
| Receivable financing | -67.05%73.03M | -52.32%149.78M | -68.38%105.88M | -89.79%52.53M | -64.03%221.63M | -49.15%314.15M | -43.68%334.83M | -6.37%514.41M | 76.20%616.16M | 131.08%617.78M |
| Other current assets | 27.07%264.93M | 14.28%219.12M | 40.71%186.41M | 64.49%174.03M | 125.79%208.49M | 97.57%191.74M | 44.94%132.48M | 34.07%105.8M | 15.10%92.34M | 57.35%97.05M |
| Total current assets | 8.12%6.07B | 13.25%6.05B | 9.70%5.9B | 0.60%5.45B | -6.29%5.62B | -6.72%5.34B | -2.46%5.38B | 0.13%5.42B | 45.81%5.99B | 35.12%5.73B |
| Non Current assets | ||||||||||
| Fixed assets | ---- | 12.85%3.4B | ---- | ---- | ---- | 18.43%3.01B | ---- | -5.78%2.8B | ---- | 27.00%2.54B |
| Constru in process | ---- | 17.87%1.6B | ---- | ---- | ---- | 66.35%1.36B | ---- | 86.98%987.61M | ---- | 122.90%818.26M |
| Intangible assets | 9.14%643.02M | 6.08%624.7M | 4.64%627.03M | 4.85%630.98M | 4.17%589.14M | 6.31%588.91M | 11.39%599.22M | 5.91%601.8M | 30.35%565.55M | 30.16%553.96M |
| Development expenditure | -52.78%38.23M | -12.35%37.17M | 193.78%37.11M | 647.17%36.69M | 290.69%80.96M | 511.41%42.4M | -35.70%12.63M | -48.66%4.91M | -41.01%20.72M | -77.50%6.94M |
| Goodwill | 0.00%192.18M | 0.00%192.18M | 0.00%192.18M | 0.00%192.18M | -2.08%192.18M | -2.08%192.18M | -2.08%192.18M | -2.08%192.18M | 0.00%196.26M | 0.00%196.26M |
| Long deferred expense | 66.07%18.9M | 64.91%11.62M | 20.42%8.66M | -52.98%2.74M | -40.79%11.38M | -20.56%7.05M | -37.18%7.19M | -24.41%5.83M | 70.69%19.22M | -8.23%8.87M |
| Deferred tax assets | 2.98%41.59M | 0.58%41.43M | 5.32%42.76M | 6.73%43.55M | -13.77%40.39M | -10.29%41.2M | -13.56%40.6M | -13.37%40.8M | -4.30%46.84M | -8.30%45.92M |
| Usufruct assets | --2.43M | --2.62M | 733.05%2.8M | 558.98%2.99M | ---- | ---- | -97.69%336.63K | -97.54%453.93K | -66.12%7.59M | -55.80%11.42M |
| Other non current assets | -81.33%9.34M | -80.91%21.93M | -92.38%14.7M | -85.68%25.34M | -39.67%50M | 54.78%114.84M | 74.73%192.91M | 23.99%176.92M | 1,578.51%82.88M | 450.82%74.2M |
| Total non current assets | 7.97%6B | 10.74%5.93B | 17.25%5.86B | 20.84%5.82B | 21.77%5.56B | 25.84%5.36B | 15.88%5B | 7.13%4.81B | 42.24%4.57B | 36.45%4.26B |
| Total assets | 8.05%12.07B | 11.99%11.98B | 13.34%11.76B | 10.12%11.27B | 5.84%11.18B | 7.17%10.7B | 5.59%10.38B | 3.31%10.23B | 44.24%10.56B | 35.69%9.99B |
| Liabilities | ||||||||||
| Current liabilities | ||||||||||
| Short term loan | 42.71%2.77B | 62.38%2.76B | 67.71%2.25B | 53.27%1.87B | 40.83%1.94B | 48.93%1.7B | 57.11%1.34B | 21.81%1.22B | 12.64%1.38B | -14.00%1.14B |
| Notes payable and accounts payable | 14.52%1.43B | 25.85%1.43B | 46.55%1.41B | 29.20%1.2B | -1.42%1.25B | 0.57%1.14B | -20.14%960.43M | 2.20%928.86M | 27.12%1.27B | 15.11%1.13B |
| -Notes payable | -5.84%470.37M | 3.08%474.89M | 63.25%466.17M | 142.79%313.56M | 23.81%499.53M | 60.55%460.71M | -52.59%285.56M | -45.37%129.15M | -11.84%403.46M | -7.50%286.96M |
| -Accounts payable | 28.07%961.8M | 41.39%954.86M | 39.49%941.38M | 10.86%886.53M | -13.19%751M | -19.86%675.35M | 12.42%674.87M | 18.92%799.71M | 60.12%865.08M | 25.56%842.68M |
| Contract liabilities | -4.72%53.21M | 95.52%72.14M | 33.60%67.92M | 25.29%47.07M | 21.23%55.85M | -4.45%36.89M | 7.41%50.84M | -24.97%37.56M | -23.16%46.07M | -52.61%38.61M |
| Salaries payable | 2.01%52.41M | 35.30%63.64M | 47.85%58.03M | 57.71%77.58M | 7.73%51.38M | -0.69%47.04M | -15.61%39.25M | -22.81%49.19M | 132.84%47.69M | 70.31%47.36M |
| Taxs payable | -14.71%13.08M | -5.12%22.09M | -21.63%25.22M | -28.99%41.2M | -33.56%15.34M | 16.43%23.29M | -0.86%32.18M | 40.68%58.02M | -41.80%23.09M | -55.20%20M |
| Other payable (including interest and dividends) | -11.52%878.42M | -10.54%870.52M | -13.87%859.99M | -12.55%850.38M | -7.07%992.74M | 12.85%973.07M | 5.44%998.49M | -3.63%972.37M | 1,239.77%1.07B | 1,187.97%862.25M |
| -Interest payable | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --3.4M | ---- |
| -Dividend payable | -82.70%8.57M | 35.54%48.38M | 59.99%45.78M | 59.99%45.78M | 56.57%49.52M | 100.13%35.69M | 614.06%28.61M | 221.33%28.61M | 62.68%31.63M | -8.27%17.84M |
| -Other payable | ---- | -12.29%822.14M | ---- | ---- | ---- | 11.01%937.37M | ---- | -5.45%943.75M | --1.03B | 1,677.61%844.42M |
| Non current liabilities due within one year | -14.94%401.84M | -37.20%399.35M | -47.97%558.29M | -37.46%731.28M | -35.83%472.43M | -6.36%635.95M | 156.17%1.07B | 37.51%1.17B | 182.32%736.24M | 83.24%679.16M |
| Other current liabilities | 30,579.61%38.03M | 63.43%22.88M | -1.91%29.17M | -52.56%77.43M | -99.83%123.97K | -89.05%14M | -80.26%29.74M | -5.32%163.19M | 825.35%72.12M | 1,106.88%127.83M |
| Total current liabilities | 17.97%5.63B | 23.54%5.64B | 16.13%5.25B | 6.46%4.9B | 2.98%4.78B | 12.86%4.57B | 22.32%4.52B | 12.24%4.6B | 72.54%4.64B | 38.99%4.05B |
| Current liabilities | ||||||||||
| Long term loan | -8.28%1.53B | 4.94%1.52B | 40.11%1.68B | 61.42%1.58B | 28.09%1.67B | 13.69%1.45B | -20.64%1.2B | -12.85%976.38M | -12.19%1.3B | -3.29%1.27B |
| Estimate liabilities | --150K | --369.81K | -85.70%369.81K | -85.70%369.81K | ---- | ---- | 16,210.42%2.59M | 16,210.42%2.59M | ---- | ---- |
| Deferred tax liabilities | 13,000.14%604.01K | 13,000.14%604.01K | 13,000.14%604.01K | 13,000.14%604.01K | --4.61K | --4.61K | --4.61K | --4.61K | ---- | ---- |
| Long term deferred income | 14.87%154.72M | 19.19%162.27M | 38.55%164.73M | 2.87%159.83M | 6.73%134.69M | 7.99%136.15M | 16.73%118.9M | 47.28%155.36M | 50.55%126.2M | 47.48%126.08M |
| Lease liabilities | --2.84M | --3.1M | --2.2M | --2.54M | ---- | ---- | ---- | ---- | -11.74%6.35M | -52.16%5.73M |
| Total non current liabilities | -6.35%1.69B | 6.42%1.69B | 39.93%1.84B | 53.34%1.74B | 25.64%1.8B | 12.71%1.58B | -18.56%1.32B | -8.16%1.13B | -8.84%1.43B | -0.64%1.4B |
| Total liabilities | 11.31%7.32B | 19.13%7.33B | 21.50%7.1B | 15.74%6.64B | 8.34%6.58B | 12.82%6.15B | 9.88%5.84B | 7.51%5.73B | 42.49%6.07B | 26.04%5.45B |
| Shareholders equity | ||||||||||
| Paid-in capital | 0.00%944.61M | 0.00%944.61M | 0.00%944.61M | 0.00%944.61M | 0.00%944.61M | 0.00%944.61M | 0.00%944.61M | 0.00%944.61M | 23.66%944.61M | 23.66%944.61M |
| Capital reserve funds | 0.00%2.51B | 0.00%2.51B | 0.00%2.51B | 0.00%2.51B | 0.00%2.51B | -3.04%2.51B | -3.04%2.51B | -5.88%2.51B | 158.58%2.51B | 166.69%2.59B |
| Surplus reserve funds | 12.06%58.96M | 12.06%58.96M | 12.06%58.96M | 12.06%58.96M | 7.33%52.62M | 10.90%52.62M | 10.90%52.62M | 10.90%52.62M | 14.75%49.03M | 11.05%47.45M |
| Retained profit | 16.30%738.09M | 8.05%660.92M | 14.70%680.49M | 15.19%656.64M | 12.45%634.66M | 15.67%611.69M | 11.63%593.26M | 10.63%570.05M | -38.35%564.41M | -41.88%528.8M |
| Specific reserves | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --10.65K | --269.73K |
| Shareholders equity without minority interests | 2.65%4.25B | 1.35%4.17B | 2.28%4.19B | 2.28%4.17B | 1.82%4.14B | 0.22%4.12B | -0.29%4.1B | -2.32%4.08B | 51.06%4.07B | 52.94%4.11B |
| Minority interests | 9.96%499.69M | 11.70%482.35M | 7.91%467.16M | 9.54%462.61M | 8.74%454.41M | 1.75%431.82M | 9.20%432.9M | 5.89%422.32M | 14.48%417.88M | 22.34%424.41M |
| Total shareholder equity | 3.37%4.75B | 2.33%4.66B | 2.82%4.66B | 2.96%4.63B | 2.46%4.6B | 0.36%4.55B | 0.54%4.53B | -1.60%4.5B | 46.69%4.49B | 49.44%4.53B |
| Total liabilityies and equity | 8.05%12.07B | 11.99%11.98B | 13.34%11.76B | 10.12%11.27B | 5.84%11.18B | 7.17%10.7B | 5.59%10.38B | 3.31%10.23B | 44.24%10.56B | 35.69%9.99B |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
| Audit Opinions | -- | -- | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- | -- |
| Auditor | -- | -- | -- | Grant Thornton Certified Public Accountants (Special General Partnership) | -- | -- | -- | Zhitong Certified Public Accountants (Special General Partnership) | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.